ℹ️
🇬🇧
Search
Search for people relevant for "MGUS"
MGUS
Person
Class
Person
Publication
Programmes
Export current view
doc. MUDr. Jakub Radocha Ph.D.
Academic staff at Faculty of Medicine in Hradec Králové
6 classes
122 publications
Classes
class
Internal Medicine I
+1
FDP033 |
Faculty of Medicine in Hradec Králové
class
Internal Medicine II
+1
FDP034 |
Faculty of Medicine in Hradec Králové
class
Internal Medicine III
+1
FDP048 |
Faculty of Medicine in Hradec Králové
Publications
publication
Importance of FLC determination in patients with MGUS and in complete remission of multiple myeloma
2012 |
Faculty of Medicine in Hradec Králové
publication
Monoclonal immunoglobulins - occurrence, importance and possibilities of their identitication
2012 |
Faculty of Medicine in Hradec Králové
publication
Prognosis of high-risk group of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)
2011 |
Faculty of Medicine in Hradec Králové
publication
Results of primary analysis from the RMG registry - importance of free short chains in the MGUS prognosis and evaluation of complete remission of MM
2011 |
Faculty of Medicine in Hradec Králové
publication
Monoclonal gammopathy of undeterminated significance: introduction and current clinical issues
2011 |
Faculty of Medicine in Hradec Králové
publication
The MGUS project - analysis of data of 616 patients from the RMG registry
2010 |
Faculty of Medicine in Hradec Králové
publication
MGUS 2010 - research project focused on identification of high-risk precancerosis
+1
2009 |
Faculty of Medicine in Hradec Králové
publication
Monoclonal gammopathies of unknown significance
+1
2008 |
Faculty of Medicine in Hradec Králové
publication
Superiority of ceftazidime off-label high-dose regimen in PK/PD target attainment during treatment of extensively drug-resistant Pseudomonas aeruginosa infections in cancer patients
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
publication
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis
2023 |
Faculty of Medicine in Hradec Králové, Central Library of Charles University, First Faculty of Medicine
Load more publications (112)
Loading network view...